Home

Investsuite

Our deals: Investsuite raised a 6M Euro Series A financial round

Join us!

We're hiring!

miracor

Client news: Miracor announces FDA IDE approval for PiCSO pivotal study

Yen

Podcast with Caesar Hao: The Voice of Hao

AcademicLabs

AGIO Capital and Business Solutions and AcademicLabs sign a strategic partnership agreement

welkin meraki

Our deals: Welkin and Meraki acquired by Industrious Office

Hackathon

Our team member won the Cronos Groep-SINC Hackathon

ls leader

Article Life Science Leader: Recognizing the Value of Biotech Partnerships in China

Agio party

Our event with Agio Legal and Agio Finance

FCCC

Online Masterclass: Understanding China's Healthcare market and its evolutions

agio s

Our strategy meeting

biotech

Our article in Bloovi: De Chinese gezondheidssector boomt en dat schept kansen voor Belgische biotech- en medtechbedrijven

Our session at Innovation for Health: Access Biotech China

Our session at Innovation for Health: Access Biotech China

international womens day

International Women's Day at AGIO Capital

Mybio article

Report MyBio: 2021 China Pharma BD Transactions Annual Report

Our article in Etion's Geëngageerd Ondernemen: De Chinese bril

Our article in Etion's Geëngageerd Ondernemen: De Chinese bril

Our podcast with Biocentury & Bayhelix: takeaways on the 8th China Healthcare Summit

Our podcast with Biocentury & Bayhelix: takeaways on the 8th China Healthcare Summit

Chinese Life Sciences sector, landscape, hubs, opportunities & future expectations

Our session at ABC: Chinese Life Sciences sector, landscape, hubs, opportunities & future expectations

Chinese big tech is dead, long live innovation

Our article in De Tijd: Chinese big tech is dead, long live innovation

Worg Pharmaceuticals to acquire Apitope International

Our deals: Worg Pharmaceuticals to acquire Apitope International

Article Reuters: Analysis: China's biotech sector comes of age with big licensing deals, global ambitions

Article Reuters: Analysis: China's biotech sector comes of age with big licensing deals, global ambitions

Biocentury Article: The mRNA therapeutics pipeline: Data Byte

Article Biocentury: The mRNA therapeutics pipeline: Data Byte

Complix’s closes Global Drug Development Deal with Jiangsu Nhwa Pharma

Our deals: Complix’s closes Global Drug Development Deal with Jiangsu Nhwa Pharma

Our article  in Mediaplanet's Life Sciences editorial together with Complix

Our article in Mediaplanet's Life Sciences editorial together with Complix

Beijing has a plan, Brussels and Washington don't...

Our article in De Tijd: Beijing has a plan, Brussels and Washington don't...

Our article in MT Magazine: China is taking the lead in times of Corona

Our article in MT Magazine: China is taking the lead in times of Corona

Our deals: OMV closes deal with Constructel

Our deals: OMV closes deal with Constructel

Our deals: Complix Signs Global Drug Discovery and Development Agreement with I-Mab

Our deals: Complix Signs Global Drug Discovery and Development Agreement with I-Mab

Our deals: Futura Medical closes deal with Co-High

Our deals: Futura Medical enters in licensing agreement with Co-High

Our article in FOKUS Business Guid: Blik op Azië

Our article in FOKUS Business Guid: Blik op Azië

AGIO joined BioIndustry Association

AGIO joined BioIndustry Association

bridge between east and west

Our article in Biovox - A bridge from East to West - linking Chinese and European biotech

Our deals: eTheRNA immunotherapies and China Grand Pharmaceutical set up AuroRNA

Our deals: eTheRNA immunotherapies and China Grand Pharmaceutical set up AuroRNA

klv

Our deals: KLV LED Light Solutions supported by us

Our deals: China partnership between Octimet Oncology and Shanghai Allist Pharmaceuticals

Our deals: China partnership between Octimet Oncology and Shanghai Allist Pharmaceuticals

A record-breaking year for investments in Belgian Biotech & Medtech companies

A record-breaking year for investments in Belgian Biotech & Medtech companies

Our article in Agoria: Coronavirus in China not only dangers, but also creates new opportunities

Our article in Agoria: Coronavirus in China not only dangers, but also creates new opportunities

Our deals: Miracor Medical

Our deals: Miracor Medical closes deal with Yonghua for series E round

Our article in Bloovi: How China managed to control Corona

Our article in Bloovi: How China managed to control Corona

Agio Capital & Business Solutions successfully supported eTheRNA immunotherapies

Our deals: eTheRNA immunotherapies closes series B investment round

Belgian Princely Mission to China

Belgian Princely Mission to China

Our article in De Tijd: The growth of the Chinese pharma market

Our article in De Tijd: The growth of the Chinese pharma market

Our article in Biovox: A bridge from east to west - linking Chinese investors with European companies

Our article in Biovox: A bridge from east to west - linking Chinese investors with European companies

Our article with VOKA: Let´s innovate together with China

Our article with VOKA: Let´s innovate together with China

Our partnership with Agoria

Our partnership with Agoria

Our deals: Promethera Biosciences supported by Co-High Medical Investment Fund

Our deals: Promethera Biosciences supported by Co-High Medical Investment Fund

Article Techcrunch: China VC has overtaken Silicon Valley

Article Techcrunch: China VC has overtaken Silicon Valley

Stay up to date